Carcinoma, Endometrioid - 11 Studies Found

Completed : POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus
:
  • Carcinoma, Endometrioid
  • mTOR Protein

: 2014-02-11
: Drug: Temsirolimus Other Name: Torisel
Withdrawn : PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion
: Ovarian Cancer
: 2005-09-12
: Procedure: immunohistochemical, methylation, gene transfection
Recruiting : Improving the Treatment for Women With Early Stage Cancer of the Uterus
:
  • Complex Endometrial Hyperplasia With Atypia
  • Grade 1 Endometrial Endome
    : 2012-09-12
    :
    • Drug: Levonorgestrel Intrauter
Active, not recruiting : The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy
:
  • Grade 1 Endometrial Endometrioid Adenocarcinoma
  • Grade 2 Endomet
    : 2014-12-22
    :
    • Drug: Depot medroxyprogesterone acetate

Recruiting : Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
:
  • Endometrial Endometrioid Adenocarcinoma
  • Endometrial Mixed Adeno
    : 2016-03-30
    :
    • Drug: Copanlisib Given IV
Completed : Mifepristone for Patients With Endometrial Cancer and LGESS
: Endometrial Cancer
: 2007-07-19
: Drug: Mifepristone 200 mg by mouth (PO) Daily x 4 Weeks
Not yet recruiting : VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer
:
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Mixed Adenocarcinoma
  • Procedure: Biopsy Undergo imag
Recruiting : Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
:
  • Fallopian Tube Clear Cell Adenocarcinoma
  • Fallopian Tube Endometrioid A
    : 2016-07-29
    :
    • Biological: Bevacizumab Given

Not yet recruiting : Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
:
  • Fallopian Tube Clear Cell Adenocarcinoma
  • Fallopian Tube Endometrioid A
    : 2016-07-20
    :
    • Drug: Atezolizumab Given IV
Recruiting : Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
:
  • Deleterious BRCA1 Gene Mutation
  • Deleterious BRCA2 Gene Mutation
  • Drug: Cediranib Maleate Given

Next >>>